Skip to main content
. 2021 Aug 6;39(39):5688–5698. doi: 10.1016/j.vaccine.2021.07.098

Table 1.

Combined data from the qualitative population surveillance study (Fig. 2) summarizing assay performance characteristics of cPass sVNT, Platelia SARS-CoV-2 Total Ab and Lumit™ Dx SARS-CoV-2 Immunoassay tests. Sensitivity, specificity, accuracy, positive and negative predictive values are shown. A prevalence of 10% was used for the calculations.

graphic file with name fx1_lrg.gif